ACS Medicinal Chemistry Letters · 2016 · 21 citations · 29 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryStructural BiologyStructure-activity RelationshipsCrystal ChemistryEnzyme InhibitionLigand BindingProtein StructureProtein-ligand InteractionsStructure-activity Relationship AnalysisProtein Interaction AnalysisProtein-ligand Binding EffectsProtein-ligand Complex ModelingSar InterpretationStructure-activity Relationship Modeling
X-ray crystal structural determination of FABP4 in complex with four inhibitors revealed the complex binding modes, and the resulting observations led to improvement of the inhibitory potency of FABP4 inhibitors. However, the detailed structure-activity relationship (SAR) could not be explained from these structural observations. For a more detailed understanding of the interactions between FABP4 and inhibitors, fragment molecular orbital analyses were performed. These analyses revealed that the total interfragment interaction energies of FABP4 and each inhibitor correlated with the ranking of the K i value for the four inhibitors. Furthermore, interactions between each inhibitor and amino acid residues in FABP4 were identified. The oxygen atom of Lys58 in FABP4 was found to be very important for strong interactions with FABP4. These results might provide useful information for the development of novel potent FABP4 inhibitors.
29
Fragment molecular orbital method: an approximate computational method for large molecules
Kazuo Kitaura, Eiji Ikeo, Toshio Asada et al. · Chemical Physics Letters · 1999 · 1.4K citations
Natural Sciences, Chemistry, Physics +10
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi, Gürol Tuncman, Cem Z. Görgün et al. · Nature · 2007 · 730 citations · Full text
Medicine, Biochemistry, Pharmacology +12